Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Restructuring Costs (2023 - 2024)

Orthofix Medical (OFIX) has disclosed Restructuring Costs for 2 consecutive years, with $1.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Restructuring Costs rose 30.72% year-over-year to $1.3 million, compared with a TTM value of $9.4 million through Dec 2024, up 697.28%, and an annual FY2024 reading of $9.4 million, up 697.28% over the prior year.
  • Restructuring Costs was $1.3 million for Q4 2024 at Orthofix Medical, up from $505000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $18.2 million in Q1 2023 and bottomed at -$18.3 million in Q3 2023.